StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences total assets

Total assets on the balance sheet at the end of each period.

ENDRA Life Sciences's total assets was $7.94M at Jun 30, 2026. For fiscal 2025 it was $3.85M, down 13.4% from the year before. The highest annual figure on record is $12.87M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.85M-13.4%
FY2024Dec 31, 2024$4.45M-34.1%
FY2023Dec 31, 2023$6.75M-27.2%
FY2022Dec 31, 2022$9.27M-28.0%
FY2021Dec 31, 2021$12.87M+46.9%
FY2020Dec 31, 2020$8.76M+22.1%
FY2019Dec 31, 2019$7.18M-0.6%
FY2018Dec 31, 2018$7.22M+17.9%
FY2017Dec 31, 2017$6.12M+1147.8%
FY2016Dec 31, 2016$490.76K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.94M+182.9%
Q1 FY2026Mar 31, 2026$3.44M+8.4%
Q4 FY2025Dec 31, 2025$3.85M-13.4%
Q3 FY2025Sep 30, 2025$1.96M-76.6%
Q2 FY2025Jun 30, 2025$2.81M-73.1%
Q1 FY2025Mar 31, 2025$3.17M-37.3%
Q4 FY2024Dec 31, 2024$4.45M-34.1%
Q3 FY2024Sep 30, 2024$8.38M+10.2%
Q2 FY2024Jun 30, 2024$10.44M+13.0%
Q1 FY2024Mar 31, 2024$5.06M-24.0%
Q4 FY2023Dec 31, 2023$6.75M-27.2%
Q3 FY2023Sep 30, 2023$7.60M-38.4%
Q2 FY2023Jun 30, 2023$9.24M-39.6%
Q1 FY2023Mar 31, 2023$6.65M-39.2%
Q4 FY2022Dec 31, 2022$9.27M-28.0%
Q3 FY2022Sep 30, 2022$12.34M-19.4%
Q2 FY2022Jun 30, 2022$15.31M-11.2%
Q1 FY2022Mar 31, 2022$10.94M-42.1%
Q4 FY2021Dec 31, 2021$12.87M+46.9%
Q3 FY2021Sep 30, 2021$15.31M+185.6%
Q2 FY2021Jun 30, 2021$17.24M+502.3%
Q1 FY2021Mar 31, 2021$18.90M+329.6%
Q4 FY2020Dec 31, 2020$8.76M+22.1%
Q3 FY2020Sep 30, 2020$5.36M+48.3%
Q2 FY2020Jun 30, 2020$2.86M-10.3%
Q1 FY2020Mar 31, 2020$4.40M-5.1%
Q4 FY2019Dec 31, 2019$7.18M-0.6%
Q3 FY2019Sep 30, 2019$3.62M+179.9%
Q2 FY2019Jun 30, 2019$3.19M+4.8%
Q1 FY2019Mar 31, 2019$4.64M+25.7%
Q4 FY2018Dec 31, 2018$7.22M+17.9%
Q3 FY2018Sep 30, 2018$1.29M-82.7%
Q2 FY2018Jun 30, 2018$3.05M-61.7%
Q1 FY2018Mar 31, 2018$3.69M+576.9%
Q4 FY2017Dec 31, 2017$6.12M+1147.8%
Q3 FY2017Sep 30, 2017$7.48M–
Q2 FY2017Jun 30, 2017$7.94M–
Q1 FY2017Mar 31, 2017$545.13K–
Q4 FY2016Dec 31, 2016$490.76K–

More ENDRA Life Sciences figures

See a number that looks wrong?